Latest NEWS
Confirmation report on the SARS-CoV-2 mutations and SAVD test diagnostic capability
FRISD
is a SARS-CoV-2 + Influenza A/B + RSV rapid, direct RT-PCR test
with internal control.
Why FRISD?
Four gene detection – SARS-CoV-2, Influenza A, Influenza B, RSV and human gene as an internal control
No RNA purification or sample preparation required
Sensitivity 98%
Specificity 100%
Limit of detection 200 copies
per ml
- Rapid RT-PCR test (results within around 30 minutes)
- Direct test (no RNA isolation step needed)
- Target sequence – ORF1ab (SARS-CoV-2), M (Influenza A), and HA (Influenza B) genes
- Internal control – RNase P gene (WHO recommendation)
- Lyophilized reagents in 8-well strips
- VTM (Viral Transport Medium) included
- Sample collection kits, pipettes and pipette tips included
- Based on GeneMe's patented enzymes
- CE IVD registered product (EU regulation)
FRISD Videos
FRISD – HOW TO PERFORM THE TEST
(DIRECT SAMPLES)
FRISD – HOW TO PERFORM THE TEST
(ISOLATED RNA SAMPLES)
About GeneMe
- Biotech company based in North Poland, operating in the field of genetic laboratory diagnostics and data analysis
- Inventor and manufcaturer of genetic tests as well as a diagnostic service provider in Poland
- Focused on reducing the time taken and accuracy of genetic analysis
- Patented technology procedure allows for the development of any other new genetic tests in 2–4 weeks if required
- Highly specialized team operating in the field of genetic diagnostics
Get in touch
GeneMe has distributors all over the world so please contact us via email biznes@geneme.eu
CONTACT
GeneMe Sp. z o.o.
ul. Kampinoska 25
80-180 Gdańsk
e-mail: biznes@geneme.eu
telephone: +48 517 169 126
availability: 9:00–17:00 CET/CEST
DOCUMENTS
Menu
All rights reserved. © 2021, GeneMe Sp. z o.o.
Design: Hajduk Studio